Study Shows Pfizer’s Vaccine Is 70% Effective Against Hospitalization From Omicron
Source: Andrew Meldrum The Associated Press, Global News, December 14th, 2021
The study has been carried out in the weeks since omicron was first announced in November by scientists in South Africa and Botswana.
A two-dose Pfizer/BioNTech vaccination provides just 33 per cent protection against infection by the omicron variant of the coronavirus, but 70 per cent protection against hospitalization, according to a large-scale analysis in South Africa released Tuesday.
The first large-scale analysis of vaccine effectiveness in the region where the new variant was discovered appears to support early indications that omicron is more easily transmissible and that the Pfizer shot isn’t as effective in protecting against infection as it was against the delta variant.
For the latest information and for more updates on everything Kindersley ‘Like’ the Kindersley Social Facebook page below…
Google Play and the Google Play logo are trademarks of Google LLC.
